Neoral dose monitoring with cyclosporine 2-hour postdose levels (C 2 ) in different renal transplant patient age groups

By Rosati A.   Bertoni E.   Zanazzi M.   Di Maria L.   Ciuti R.   Piperno R.   Moscarelli L.   Biagini M.   Salvadori M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3106-3107

Elsevier

Access to resources Recommend Favorite

Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction

By Cantarovich M.   de Gruchy S.   Forbes C.   Marpole D.   Elstein E.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 79-79

Elsevier

Access to resources Recommend Favorite

Bolus anti-thymocyte globulin induction in renal transplant recipients: a comparison with conventional ATG or anti-interleukin-2 receptor antibody induction

By Nampoory M.R.N.   Abdulhalim M.   Johny K.V.   Al-Jawad Donia F.A.   Nair M.P.   Said T.   Homoud H.   Samhan M.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2916-2919

Elsevier

Access to resources Recommend Favorite

Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients

By Abou-Jaoude M.M.   Ghantous I.   Najm R.   Afif C.   Almawi W.Y.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2731-2732

Elsevier

Access to resources Recommend Favorite

Comparison of Cyclosporine Monitoring With Trough Levels to Levels Obtained 6 Hours After the Morning Dose in Heart Transplant Patients: A Prospective Randomized Study

By Cantarovich M.   Latter D.   Fitchett D.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 602-604

Elsevier

Access to resources Recommend Favorite